Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome
- PMID: 36038686
- DOI: 10.1007/s00417-022-05811-6
Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome
Abstract
Purpose: To compare the surgical outcomes of the Aurolab aqueous drainage implant (AADI) and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to iridocorneal endothelial (ICE) syndrome.
Materials and methods: This retrospective comparative case series included 41 eyes of 41 patients with ICE syndrome and glaucoma who underwent either a trabeculectomy with MMC (n = 20) or AADI surgery (n = 21) with a minimum of 2 years follow-up. Outcome measures included intraocular pressure (IOP), the use of glaucoma medications, visual acuity, additional surgical interventions, and surgical complications. Surgical failure was defined as IOP > 21 mmHg or reduced < 20% from baseline, IOP ≤ 5 mmHg, reoperation for glaucoma or a complication, or loss of light perception vision.
Results: The cumulative probability of failure at 2 years was 50% in the trabeculectomy group (95%CI = 31-83%) and 24% in the AADI group (95%CI = 11-48%) (p = 0.09). The IOP was consistently lower in the AADI group compared with the trabeculectomy group at 6 months and thereafter. Surgical complications occurred in 13 eyes (65%) in the trabeculectomy group and 12 eyes (57%) in the AADI group (p = 0.71). Reoperations for glaucoma or complications were performed in 12 eyes (60%) in the trabeculectomy group and 5 patients (24%) in the tube group (p = 0.06). Cox proportional hazards showed that AADI had a 53% lower risk of failure at 2 years (p = 0.18; HR = 0.47; 95%CI = 0.16-1.40).
Conclusion: AADI surgery achieved lower mean IOPs than trabeculectomy with MMC in managing glaucoma secondary to ICE syndrome. A trend toward lower rates of surgical failure and reoperations for glaucoma and complications was observed following AADI placement compared with trabeculectomy with MMC in eyes with ICE syndrome.
Keywords: Aurolab aqueous drainage implant; Glaucoma drainage devices; Iridocorneal endothelial syndrome; Trabeculectomy with mitomycin.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Shields MB (1979) Progressive essential iris atrophy, Chandler’s syndrome, and the iris nevus (Cogan-Reese) syndrome: a spectrum of disease. Surv Ophthalmol 24:3–20. https://doi.org/10.1016/0039-6257(79)90143-7 - DOI
-
- Campbell DG, Shields MB, Smith TR (1978) The corneal endothelium and the spectrum of essential iris atrophy. Am J Ophthalmol 86:317–324. https://doi.org/10.1016/0002-9394(78)90232-5 - DOI
-
- Hirst LW, Quigley HA, Stark WJ, Shields MB (1980) Specular microscopy of iridocorneal endothelia syndrome. Am J Ophthalmol 89:11–21. https://doi.org/10.1016/0002-9394(80)90223-8 - DOI
-
- Sacchetti M, Mantelli F, Marenco M, et al (2015) Diagnosis and management of iridocorneal endothelial syndrome. Biomed Res Int 763093. https://doi.org/10.1155/2015/763093
-
- Silva L, Najafi A, Suwan Y, Teekhasaenee C, Ritch R (2018) The iridocorneal endothelial syndrome. Surv Ophthalmol 63:665–676 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical